This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Aftabul Haque: Innovator in Neurodegenerative Disorder Research
Introduction
Aftabul Haque is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of biomedical research, particularly in understanding and addressing neurodegenerative disorders.
Latest Patents
Aftabul Haque holds a patent titled "Amyloid beta expression constructs and uses therefor." This patent discloses yeast expression constructs that encode a polypeptide containing a signal sequence, a Golgi-directing pro sequence, and a human amyloid beta protein. Additionally, it includes mammalian expression constructs that encode a polypeptide with a selected signal sequence and a human amyloid beta protein. The patent also outlines methods for screening cells to identify compounds that can prevent or suppress amyloid beta-induced toxicity, as well as genetic suppressors or enhancers of this toxicity. Compounds identified through these screens have potential applications in treating or preventing neurodegenerative disorders, such as Alzheimer's disease.
Career Highlights
Aftabul Haque is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His work focuses on innovative approaches to tackle complex biological problems related to neurodegeneration.
Collaborations
Aftabul has collaborated with esteemed colleagues, including Susan Lindquist and Susan L Lindquist, who are also recognized for their contributions to the field of biomedical research.
Conclusion
Aftabul Haque's innovative work in developing expression constructs and screening methods represents a significant advancement in the fight against neurodegenerative diseases. His contributions continue to inspire further research and development in this critical area of health.